Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practice

[1]  B. Nordestgaard,et al.  Socioeconomic Status and Prognosis of COPD in Denmark , 2014, COPD.

[2]  S. Wyke,et al.  The influence of socioeconomic deprivation on multimorbidity at different ages: a cross-sectional study , 2014, The British journal of general practice : the journal of the Royal College of General Practitioners.

[3]  W. Maier,et al.  Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: a systematic literature review , 2014, International Journal for Equity in Health.

[4]  M. Woodward,et al.  Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events , 2014, Diabetologia.

[5]  Nicolas Roche,et al.  Impact of gender on COPD expression in a real-life cohort , 2014, Respiratory Research.

[6]  J. Browne,et al.  GPs’ perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research , 2013, BMJ Open.

[7]  Florent Baty,et al.  Comorbidities and Burden of COPD: A Population Based Case-Control Study , 2013, PloS one.

[8]  Silvio E. Inzucchi,et al.  Personalized Management of Hyperglycemia in Type 2 Diabetes , 2013, Diabetes Care.

[9]  Jos W. R. Twisk,et al.  Applied Longitudinal Data Analysis for Epidemiology: References , 2013 .

[10]  V. Basevi.  Standards of Medical Care in Diabetes—2013 , 2012, Diabetes Care.

[11]  Tjard Schermer,et al.  Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study , 2012, BMC Medicine.

[12]  Joan B. Soriano,et al.  Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice , 2012, European Respiratory Journal.

[13]  Ran Wang,et al.  Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-Analysis , 2012, PloS one.

[14]  S. Wyke,et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.

[15]  C. van Weel,et al.  GPs' considerations in multimorbidity management: a qualitative study. , 2012, The British journal of general practice : the journal of the Royal College of General Practitioners.

[16]  Differential Effects of Comorbidity on Antihypertensive and Glucose-Regulating Treatment in Diabetes Mellitus – A Cohort Study , 2012, PloS one.

[17]  H. van den Bussche,et al.  The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. first results from the multicare cohort study , 2012, BMC Health Services Research.

[18]  C. van Weel,et al.  Health Care in The Netherlands , 2012, The Journal of the American Board of Family Medicine.

[19]  M. Souto-Gallardo,et al.  Effect of weight loss on metabolic control in people with type 2 diabetes mellitus: systematic review. , 2011, Nutricion hospitalaria.

[20]  Gert P. Westert,et al.  Current Guidelines Have Limited Applicability to Patients with Comorbid Conditions: A Systematic Analysis of Evidence-Based Guidelines , 2011, PloS one.

[21]  T. Urech,et al.  Impact of Comorbidity Type on Measures of Quality for Diabetes Care , 2011, Medical care.

[22]  S. Subramanian,et al.  Lifecourse socioeconomic circumstances and multimorbidity among older adults , 2011, BMC public health.

[23]  M. S. Kirkman,et al.  Response to Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61 , 2011, Diabetes Care.

[24]  N. Seleno.  Prevalence of Major Comorbidities in Subjects with COPD and Incidence of Myocardial Infarction and Stroke: a Comprehensive Analysis Using Data from Primary Care , 2011 .

[25]  M. Tinetti,et al.  Primary care clinicians' experiences with treatment decision making for older persons with multiple conditions. , 2010, Archives of internal medicine.

[26]  S. Suissa,et al.  Inhaled corticosteroids and the risks of diabetes onset and progression. , 2010, The American journal of medicine.

[27]  Diederick E. Grobbee,et al.  The global burden of diabetes and its complications: an emerging pandemic , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[28]  C. van Weel,et al.  Trends in COPD prevalence and exacerbation rates in Dutch primary care. , 2009, The British journal of general practice : the journal of the Royal College of General Practitioners.

[29]  Irina Tolstykh,et al.  Socioeconomic status, race and COPD health outcomes , 2009, Journal of Epidemiology & Community Health.

[30]  C. van Weel,et al.  Yield of Opportunistic Targeted Screening for Type 2 Diabetes in Primary Care: The Diabscreen Study , 2009, The Annals of Family Medicine.

[31]  C. van Weel,et al.  The risk for depression comorbidity in patients with COPD. , 2009, Chest.

[32]  D. Mannino,et al.  Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD , 2008, European Respiratory Journal.

[33]  C. van Weel.  The Continuous Morbidity Registration Nijmegen: background and history of a Dutch general practice database. , 2008, The European journal of general practice.

[34]  N. Anthonisen,et al.  Mortality in COPD: role of comorbidities , 2006, European Respiratory Journal.

[35]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[36]  M. Hoogendoorn,et al.  Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. , 2006, Respiratory medicine.

[37]  J. Walters,et al.  Oral corticosteroids for stable chronic obstructive pulmonary disease. , 2005, The Cochrane database of systematic reviews.

[38]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[39]  S. Montgomery,et al.  Applied longitudinal data analysis for epidemiology: , 2005, European Journal of Epidemiology.

[40]  C. van Weel,et al.  Chronic functional somatic symptoms: a single syndrome? , 2004, The British journal of general practice : the journal of the Royal College of General Practitioners.

[41]  A. Wu,et al.  Preventable hospitalization among elderly Medicare beneficiaries with type 2 diabetes. , 2003, Diabetes care.

[42]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[43]  C. van Weel,et al.  Outcomes of audit-enhanced monitoring of patients with type 2 diabetes. , 2002, The Journal of family practice.

[44]     ,et al.  NHG-Standaard COPD en Astma bij Volwassenen: Diagnostiek , 2001 .

[45]  Terje R Pedersen,et al.  Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.

[46]  Ivo Smeele,et al.  COPD en astma bij volwassenen: Diagnostiek. NHG-standaard , 1997 .

[47]  Marjan van den Akker,et al.  Comorbidity or multimorbidity: what's in a name ? A review of literature , 1996 .

[48]  C. van Weel,et al.  Validating long term morbidity recording. , 1995, Journal of epidemiology and community health.

[49]  Yrjö Jahnsson,et al.  In Denmark , 1905 .